JNJ-77242113
Janssen
['psoriasis']
wcd 2023 day 2 afternoon - phase ii trial for an oral peptide to treat plaque psoriasis dr. ronald b. vender discusses the late breaking study that everyone is talking about, an #oral #peptide to treat moderate-to-severe plaque #psoriasis. 
Up-to-date clinical news for dermatology. Publishers of The Chronicle of Skin & Allergy, The Chronicle of Cosmetic Medicine & Surgery, & Skin Spectrum Summit